Table of Contents

· Inhalt · Sommaire.- Treatment of helminth diseases — challenges and achievements.- Ribonucleotide reductase inhibitors as anticancer and antiviral agents.- Pyrimidinones as biodynamic agents.- Enzyme inhibitors of the renin-angiotensin system.- Cooperative effects in drug-DNA interactions.- GABA-drug interactions.- Quinolones.- Risk assessment problems in chemical oncogenesis.- The pharmacology of caffeine.- Mechanism of action of anxiolytic drugs.- In vitro models for the study of antibiotic activities.- Light and dark as a “drug”.- High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development.- Index · Sachverzeichnis · Table des matières, Vol. 31.- Index of titles · Verzeichnis der Titel · Index des titres, Vol. 1–31.- Author and paper index · Autoren- und Artikelindex · Index des auteurs et des articles, Vol. 1–31.